Changes in Body- and Liver-composition During Low Calorie Diet in Morbidly Obese
NCT ID: NCT01842425
Last Updated: 2013-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2012-10-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Morbidly obese female patients awaiting laparoscopic gastric bypass are recruited. They are, as all our patients, treated during four weeks with LCD to achieve a decrease in liver size. During this period they are examined on day 0, 3, 7, 14 and 28 after commencing LCD.
At each evaluation, body composition is assessed through bioelectric impedance analysis (BIA), liver volume and intrahepatic fat through magnetic resonance imaging. A questionnaire regarding quality of life and LCD-related symptoms is administered as well. At surgery two samples of subcutaneous fat and one sample of omental fat is taken.
We do not assign patients to different treatments, instead all are treated similarly according to our routine preoperative regimen.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Residing near Uppsala
Exclusion Criteria
* Metal implants such as pacemaker or intracerebral clips
* Failure to understand or comply with study protocol
20 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
DEdholm
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Edholm, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of surgery, Akademiska sjukhuset
Uppsala, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
David Edholm, Dr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MR-LCD2
Identifier Type: -
Identifier Source: org_study_id